Johan van Hylckama Vlieg

Company: Freya Biosciences

Job title: Chief Scientific Officer & Co-Founder

Seminars:

Leveraging Microbial Immunotherapies for Bacterial Vaginosis: Innovations with the DYSCOVER Platform 2:00 pm

Developing microbial immunotherapies for Bacterial Vaginosis (BV) using the DYSCOVER platform to address the imbalance in the vaginal microbiome and reduce inflammation Leveraging proof-of-concept studies (DYSCOVER-1 and Dyscover II) to demonstrate the efficacy of Lactobacillus strains in engrafting the vaginal tract and displacing dysbiotic microbiomes Mitigating serious consequences in pregnant women by reducing the recurrence…Read more

day: Conference Day Two, Track Two, PM

Roundtable: Advancing Microbiome Therapeutics: Insights from the MTIG and EMIH Collaboration 8:00 am

How can harmonized regulatory frameworks benefit microbiome therapeutics across different regions, and what specific steps can be taken to achieve this harmonization? What innovative strategies can be employed to accelerate the development of microbiome-based therapies through international collaboration, and how can these strategies be effectively implemented? How can expanding access to microbiome therapies benefit the…Read more

day: Conference Day Two, 7:30 - 10:00